Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy

por Shaheen, N. J., Adler, J., Dedrie, S., Johnson, D., Malfertheiner, P., Miner, P., Meulemans, A., Poole, L., Tack, J., Thielemans, L., Troy, S., Vakil, N., Zerbib, F., Ruth, M.
Publicado 2015

Randomized clinical trial: effect of the 5-HT(4) receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment

por Tack, J, Zerbib, F, Blondeau, K, des Varannes, S B, Piessevaux, H, Borovicka, J, Mion, F, Fox, M, Bredenoord, A J, Louis, H, Dedrie, S, Hoppenbrouwers, M, Meulemans, A, Rykx, A, Thielemans, L, Ruth, M
Publicado 2015

Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014

por Thielemans, L., Trip-Hoving, M., Landier, J., Turner, C., Prins, T. J., Wouda, E. M. N., Hanboonkunupakarn, B., Po, C., Beau, C., Mu, M., Hannay, T., Nosten, F., Van Overmeire, B., McGready, R., Carrara, V. I.
Publicado 2018